Seer Stock

seer.bioHealthcareFounded: 2017Funding to Date: $108.5MM

Seer is a provider of innovative solutions that act as a gateway to the proteome.

Register for Details

For more details on financing and valuation for Seer, register or login.

Please provide your first name.
Please provide your last name.
Please provide a valid email address.

By registering, you agree to the Forge Terms of Use. Already registered? Click here to log in

Enterprise Value (based on primary financings)

Enterprise Value

View Enterprise Value for Seer.

Register Today

Team

Management Team

Robert Langer Ph.D
Co-Founder, Board Member & Chairman of Scientific Advisory Board
Omid Farokhzad MD
Co-Founder, Chief Executive Officer & Board Member
Philip Ma Ph.D
Co-Founder, President & Chief Business Officer

Board Members

Mark McClellan Ph.D
Terrance McGuire
David Hallal
Omid Farokhzad MD
David Singer
Maverick Ventures
Robert Langer Ph.D

Other companies like Seer in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$3.6B
Sector
Last Round Est. Valuation
$334.19MM
Sector
Last Round Est. Valuation
$150MM
Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$296.3MM
Sector
Last Round Est. Valuation
$4.8B

News

The company posted revenues of $3.1 million, up from $336,000 in the year-ago period and beating the consensus Wall Street estimate of $2.2 million.
The company and its early-access users have recently published data from several studies indicating that its platform can boost plasma proteome coverage.
The company posted revenues of $1.3 million, up from $71,000 in the year-ago period and above the consensus Wall Street estimate of $790,000.